Laboratory of Nutrition, Graduate School of Agricultural Science, Tohoku University, Sendai, 981-8555, Japan.
Amino Acids. 2012 Dec;43(6):2545-51. doi: 10.1007/s00726-012-1406-8. Epub 2012 Sep 30.
Chronic ethanol consumption induces liver diseases, such as alcoholic hepatitis and cirrhosis. The enhancement of alcohol oxidation is important in the prevention of these liver diseases. Chronic supplementation with branched chain amino acids (BCAAs) prevents liver cirrhosis. Therefore, BCAAs may be associated with enhanced ethanol oxidation. To evaluate this hypothesis, we investigated the effect of the administration of individual BCAAs on ethanol oxidation and changes in alcohol-metabolizing enzyme activities following acute alcohol intake in rats. Blood ethanol concentrations and the activities of alcohol-metabolizing enzymes, such as alcohol dehydrogenase (ADH) and low and high Km aldehyde dehydrogenase (ALDH), were measured in the liver following acute ethanol administration in rats; the ethanol was administered 30 min after the treatment with amino acids [such as leucine (Leu), isoleucine (Ile), valine (Val) or alanine (Ala)]. Leu significantly decreased the blood ethanol concentration 1 h after ethanol administration compared to the water-treated control (C) [C 0.46 ± 0.09, Leu 0.18 ± 0.04, Ile 0.27 ± 0.09, Val 0.46 ± 0.1, Ala 0.43 ± 0.06, mean ± SEM (g/l), P < 0.05]. In addition, leucine significantly stimulated ADH activity 30 min after ethanol intake [C 0.042 ± 0.014, Leu 0.090 ± 0.016, Ile 0.042 ± 0.008, Val 0.022 ± 0.010, Ala 0.070 ± 0.016, mean ± SEM (unit/mg protein), P < 0.05] and low Km ALDH activity 15 min after ethanol intake [C 0.51 ± 0.63, Leu 3.72 ± 0.66, Ile 1.26 ± 0.89, Val: ND, Ala 1.86 ± 1.57, mean ± SEM (unit/mg protein), P < 0.05]. However, leucine and its metabolite α-keto-isocaproic acid did not enhance ethanol clearance in isolated rat hepatocytes. These results indicate that leucine accelerates ethanol oxidation by indirectly enhancing ADH and low Km ALDH activities in the liver.
慢性乙醇摄入可导致肝脏疾病,如酒精性肝炎和肝硬化。增强酒精氧化对于预防这些肝脏疾病很重要。慢性补充支链氨基酸(BCAA)可预防肝硬化。因此,BCAA 可能与增强的乙醇氧化有关。为了评估这一假设,我们研究了在大鼠急性酒精摄入后,单独给予 BCAAs 对乙醇氧化和酒精代谢酶活性变化的影响。在大鼠急性给予乙醇后,测量肝脏中的血乙醇浓度和酒精代谢酶(如乙醇脱氢酶(ADH)和低 Km 醛脱氢酶(ALDH))的活性;在给予氨基酸[如亮氨酸(Leu)、异亮氨酸(Ile)、缬氨酸(Val)或丙氨酸(Ala)] 30 分钟后给予乙醇。与水治疗对照(C)相比,Leu 在乙醇给药后 1 小时显著降低血乙醇浓度[C 0.46 ± 0.09,Leu 0.18 ± 0.04,Ile 0.27 ± 0.09,Val 0.46 ± 0.1,Ala 0.43 ± 0.06,均值 ± SEM(g/l),P < 0.05]。此外,亮氨酸在摄入乙醇后 30 分钟显著刺激 ADH 活性[C 0.042 ± 0.014,Leu 0.090 ± 0.016,Ile 0.042 ± 0.008,Val 0.022 ± 0.010,Ala 0.070 ± 0.016,均值 ± SEM(单位/毫克蛋白),P < 0.05]和低 Km ALDH 活性 15 分钟[C 0.51 ± 0.63,Leu 3.72 ± 0.66,Ile 1.26 ± 0.89,Val:ND,Ala 1.86 ± 1.57,均值 ± SEM(单位/毫克蛋白),P < 0.05]。然而,亮氨酸及其代谢物α-酮异己酸并没有增强分离大鼠肝细胞中的乙醇清除率。这些结果表明亮氨酸通过间接增强肝脏中的 ADH 和低 Km ALDH 活性来加速乙醇氧化。